Dilated cardiomyopathy with left ventricular thrombi as a presenting feature of Cushing disease

Ji Hye Kim1, So Young Kim2, Ji Hyun Park3

  • 1Department of Internal Medicine, Presbyterian Medical Center, Jeonju, Republic of Korea.

Insights

Cushing disease (CD) can cause heart failure and blood clots in young adults. Surgical treatment of CD led to improved heart function and clot resolution, highlighting the link between hormonal imbalance and cardiovascular health.

Area of Science:

  • Cardiology
  • Endocrinology
  • Internal Medicine

Background:

  • Cushing disease (CD) is a rare endocrine disorder caused by excess cortisol.
  • Cardiovascular complications, including cardiomyopathy and thromboembolism, are known risks in CD.
  • The interplay between cortisol excess and cardiac dysfunction requires further elucidation.

Observation:

  • A 20-year-old male patient presented with symptomatic heart failure.
  • Echocardiography revealed dilated cardiomyopathy and two left ventricular apical thrombi.
  • The patient had a confirmed diagnosis of Cushing disease.

Findings:

  • Intracardiac thrombi resolved following intravenous heparin therapy.
  • Symptomatic treatment and subsequent trans-sphenoidal adenomectomy were performed.
  • Cardiac function progressively improved over 3 years post-surgery, suggesting a link between CD management and cardiac recovery.

Implications:

  • This case underscores the importance of recognizing and managing cardiovascular manifestations in Cushing disease.
  • Effective treatment of the underlying endocrine disorder can lead to significant improvement in cardiac function.
  • Further research into the mechanisms of cortisol-induced cardiomyopathy is warranted.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
775
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
793
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
9
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...
16
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
809
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
930